207 related articles for article (PubMed ID: 20720025)
21. Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study.
De Vlieger G; Lagrou K; Maertens J; Verbeken E; Meersseman W; Van Wijngaerden E
J Clin Microbiol; 2011 Nov; 49(11):3783-7. PubMed ID: 21880959
[TBL] [Abstract][Full Text] [Related]
22. [Multiple serum antigenic assays for diagnosis of invasive fungal infections in non-neutropenic adult patients].
Jin J; Sun TY; Hu YJ; Li YM
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):660-4. PubMed ID: 21092632
[TBL] [Abstract][Full Text] [Related]
23. A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection: Focus on cutoff levels.
He S; Hang JP; Zhang L; Wang F; Zhang DC; Gong FH
J Microbiol Immunol Infect; 2015 Aug; 48(4):351-61. PubMed ID: 25081986
[TBL] [Abstract][Full Text] [Related]
24. Retrospective assessment of β-D-(1,3)-glucan for presumptive diagnosis of fungal infections.
Bellanger AP; Grenouillet F; Henon T; Skana F; Legrand F; Deconinck E; Millon L
APMIS; 2011 Apr; 119(4-5):280-6. PubMed ID: 21492228
[TBL] [Abstract][Full Text] [Related]
25. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.
Odabasi Z; Mattiuzzi G; Estey E; Kantarjian H; Saeki F; Ridge RJ; Ketchum PA; Finkelman MA; Rex JH; Ostrosky-Zeichner L
Clin Infect Dis; 2004 Jul; 39(2):199-205. PubMed ID: 15307029
[TBL] [Abstract][Full Text] [Related]
26. (1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.
Azoulay E; Guigue N; Darmon M; Mokart D; Lemiale V; Kouatchet A; Mayaux J; Vincent F; Nyunga M; Bruneel F; Rabbat A; Bretagne S; Lebert C; Meert AP; Benoit D; Pene F
Oncotarget; 2016 Apr; 7(16):21484-95. PubMed ID: 26910891
[TBL] [Abstract][Full Text] [Related]
27. [The effect of albumin on (1, 3)-β-D-glucan for diagnosis of invasive fungal infections].
Han S; Su X; Zhao R; Fang K
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):672-6. PubMed ID: 26255017
[TBL] [Abstract][Full Text] [Related]
28. [The diagnostic value of detecting plasma 1, 3-beta-D-glucan for invasive fungal infections].
Lü PH; Zhao BL; Shi Y; Wen YT
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jan; 30(1):31-4. PubMed ID: 17326970
[TBL] [Abstract][Full Text] [Related]
29. Contribution of (1,3)-beta-D-glucan to diagnosis of invasive candidiasis after liver transplantation.
Levesque E; El Anbassi S; Sitterle E; Foulet F; Merle JC; Botterel F
J Clin Microbiol; 2015 Mar; 53(3):771-6. PubMed ID: 25520448
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.
Zheng F; Zha H; Yang D; Deng J; Zhang Z
Mycopathologia; 2017 Apr; 182(3-4):331-338. PubMed ID: 27664106
[TBL] [Abstract][Full Text] [Related]
31. Performance Characteristics of Galactomannan and β-d-Glucan in High-Risk Liver Transplant Recipients.
Singh N; Winston DJ; Limaye AP; Pelletier S; Safdar N; Morris MI; Meneses K; Busuttil RW; Wagener MM; Wheat LJ
Transplantation; 2015 Dec; 99(12):2543-50. PubMed ID: 26050015
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.
Koo S; Bryar JM; Page JH; Baden LR; Marty FM
Clin Infect Dis; 2009 Dec; 49(11):1650-9. PubMed ID: 19863452
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.
Onishi A; Sugiyama D; Kogata Y; Saegusa J; Sugimoto T; Kawano S; Morinobu A; Nishimura K; Kumagai S
J Clin Microbiol; 2012 Jan; 50(1):7-15. PubMed ID: 22075593
[TBL] [Abstract][Full Text] [Related]
34. Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study.
Cento V; Alteri C; Mancini V; Gatti M; Lepera V; Mazza E; Moioli MC; Merli M; Colombo J; Orcese CA; Bielli A; Torri S; Gasparini LE; Vismara C; De Gasperi A; Brioschi P; Puoti M; Cairoli R; Lombardi G; Perno CF
Mycoses; 2020 Dec; 63(12):1299-1310. PubMed ID: 32810888
[TBL] [Abstract][Full Text] [Related]
35. Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients.
Hammarström H; Stjärne Aspelund A; Christensson B; Heußel CP; Isaksson J; Kondori N; Larsson L; Markowicz P; Richter J; Wennerås C; Friman V
Mycoses; 2018 Sep; 61(9):623-632. PubMed ID: 29577474
[TBL] [Abstract][Full Text] [Related]
36. β-D-Glucan Screening for Detection of Invasive Fungal Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Koltze A; Rath P; Schöning S; Steinmann J; Wichelhaus TA; Bader P; Bochennek K; Lehrnbecher T
J Clin Microbiol; 2015 Aug; 53(8):2605-10. PubMed ID: 26041896
[TBL] [Abstract][Full Text] [Related]
37. Clinical viability of Fungitell, a new (1→3)-β-D: -glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan.
Yoshida K; Shoji H; Takuma T; Niki Y
J Infect Chemother; 2011 Aug; 17(4):473-7. PubMed ID: 21210174
[TBL] [Abstract][Full Text] [Related]
38. β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis.
Karageorgopoulos DE; Vouloumanou EK; Ntziora F; Michalopoulos A; Rafailidis PI; Falagas ME
Clin Infect Dis; 2011 Mar; 52(6):750-70. PubMed ID: 21367728
[TBL] [Abstract][Full Text] [Related]
39. Reappraisal of the serum (1-->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years.
Obayashi T; Negishi K; Suzuki T; Funata N
Clin Infect Dis; 2008 Jun; 46(12):1864-70. PubMed ID: 18462174
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]